2 assets in Acute Chest Syndrome

Therapeutic assets addressing Acute Chest Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tocilizumab Acute Chest Syndrome	Assistance Publique - Hôpitaux de Paris	P3	BB (65)
Iohexol Acute Chest Syndrome	University Hospital, Tours	N/A	D (30)